- $32.23bn
- $32.68bn
- $4.34bn
Brief: Illumina Introduces Billion Cell Atlas To Accelerate Ai And Drug Discovery
Illumina unveils dataset to speed up AI-powered drug discovery
Brief: Illumina Introduces Billion Cell Atlas, Genome-Wide Genetic Perturbation Dataset
Illumina Q4 preliminary revenue rises 5%, beats analyst expectations
Life sciences and contract research stocks navigate turbulence in 2025
Jefferies updates ratings on life sciences firms for 2026
Brief: Illumina Inc Files For Offering Of $500 Million 4.750% Notes Due 2030
Timeline: Trump's trade war with China in 2025
U.S. RESEARCH ROUNDUP-Doordash, Honeywell, Zscaler
Timeline: Trump's trade war with China in 2025
Brief: Illumina Responds To Positive Updates From Chinese Ministry Of Commerce
U.S. STOCKS ON THE MOVE-Targa Resources, Illumina, Alphabet
Illumina rises after China lifts export ban, Evercore sees growth in FY26
Illumina surges on Q3 results beat, FY profit forecast raise
Genomics company Illumina Q3 revenue beats expectations, helped by clinical market growth
Brief: Illumina Q3 Adjusted EPS USD 1.34 Vs. IBES Estimate USD 1.17
10x sues rival Illumina over gene-sequencing patents
Brief: Illumina Constellation Mapped Read Technology Uncovers Hard-To-See Genomic Insights In GeneDx Pilot
Timeline: Trump's trade war with China in 2025